These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

179 related items for PubMed ID: 4242380

  • 1. [Selective inhibition of myocardial contractility by competitive divalent Ca++ antagonists (iproveratril, D 600, prenylamine)].
    Fleckenstein A, Tritthart H, Fleckenstein B, Herbst A, Grün G.
    Naunyn Schmiedebergs Arch Pharmakol; 1969; 264(3):227-8. PubMed ID: 4242380
    [No Abstract] [Full Text] [Related]

  • 2. [A new group of competitive divalent Ca-antagonists (iproveratril, D 600, prenylamine) with potent inhibitory effects on electromechanical coupling in mammalian myocardium].
    Fleckenstein A, Tritthart H, Flackenstein B, Herbst A, Grün G.
    Pflugers Arch; 1969; 307(2):R25. PubMed ID: 5814829
    [No Abstract] [Full Text] [Related]

  • 3. [Parallel influence of isometric tension development and O2 consumption of isolated papillary muscles under the influence of Ca ions, adrenaline, isoproteranol and organic Ca antagonists (iproveratril, D 600, prenylamine)].
    Byon KY, Fleckenstein A.
    Pflugers Arch; 1969; 312(1):R8-9. PubMed ID: 5390309
    [No Abstract] [Full Text] [Related]

  • 4. [Separation of the divalent Ca++ antagonistic effect component from the beta-adrenolytic effects of cardio-depressive drugs on cultures of embryonic heart muscle cells].
    Kaufmann R, Tritthart H, Rost B.
    Naunyn Schmiedebergs Arch Pharmakol; 1969; 264(3):252-3. PubMed ID: 4242400
    [No Abstract] [Full Text] [Related]

  • 5. [Reversible blockade of excitation-contraction coupling in rat's uterine smooth muscle by means of organic calcium antagonists (iproveratril, D 600, prenylamine)].
    Fleckenstein A, Grün G.
    Pflugers Arch; 1969; 307(2):R26. PubMed ID: 5814830
    [No Abstract] [Full Text] [Related]

  • 6. [On the method of action of new types of coronary dilatators with simultaneous oxygen-saving myocardial effects, prenylamine and iproveratril. 2].
    Fleckenstein A, Kammermeier H, Döring HJ, Freund HJ.
    Z Kreislaufforsch; 1967 Aug; 56(8):839-58. PubMed ID: 5592708
    [No Abstract] [Full Text] [Related]

  • 7. [Limitation of the disappearance of energy-rich phosphate compounds in the hyperactive atrial and ventricular myocardium by divalent Ca-antagonistic inhibitors of electromechanical coupling (iprovdratril, D 600, prenylamine)].
    Doring HJ, Leder O, Jaedicke W, Reindell A, Fleckenstein A.
    Pflugers Arch; 1969 Aug; 312(1):R7-8. PubMed ID: 5390299
    [No Abstract] [Full Text] [Related]

  • 8. [Effect of beta-receptor blocking agents and related substances on the excitation, contraction and energy metabolism of myocardium fibers].
    Fleckenstein A, Döring HJ, Kammermeier H.
    Klin Wochenschr; 1968 Apr 01; 46(7):343-51. PubMed ID: 4386795
    [No Abstract] [Full Text] [Related]

  • 9. [On the action mechanism of new coronary dilators with simultaneous oxygen saving myocardial effects, Prenylamine and Iproveratril. 1].
    Fleckenstein A, Kammermeier H, Döring HJ, Freund HJ.
    Z Kreislaufforsch; 1967 Jul 01; 56(7):716-44. PubMed ID: 5592004
    [No Abstract] [Full Text] [Related]

  • 10. [Uterus relaxation by highly potent Ca plus,plus-antagonistic inhibitors of electro-mechanical coupling such as Isoptin (verapamil, iproveratril), compound D 600 and Segontin (prenylamine). Experiments on the isolated virgin rat uterus].
    Fleckenstein A, Grün G, Tritthart H, Byon K.
    Klin Wochenschr; 1971 Jan 01; 49(1):32-41. PubMed ID: 5545957
    [No Abstract] [Full Text] [Related]

  • 11. [Electromechanical uncoupling on the uterine muscle by "musculotropic" relaxants].
    Grün G, Fleckenstein A, Tritthart H.
    Naunyn Schmiedebergs Arch Pharmakol; 1969 Jan 01; 264(3):239-40. PubMed ID: 4242391
    [No Abstract] [Full Text] [Related]

  • 12. [Protective effect of organic Ca antagonists (iproveratril, D 600, prenylamine) against isoproterenol-induced myocardial necrosis].
    Leder O, Döring HJ, Reindell A, Fleckenstein A.
    Pflugers Arch; 1969 Jan 01; 312(1):R9-10. PubMed ID: 5390319
    [No Abstract] [Full Text] [Related]

  • 13. [Influence of active antiarrhythmia substances on refractory period and contractility of guinea pig atria].
    Heeg E, Reuter N, Steiger H.
    Naunyn Schmiedebergs Arch Pharmakol; 1969 Jan 01; 264(3):244-5. PubMed ID: 4243341
    [No Abstract] [Full Text] [Related]

  • 14. [Studies on the mechanism of action of INPEA, iproveratril and oxyfedrin].
    Bosse JA, Schaum E.
    Naunyn Schmiedebergs Arch Pharmakol; 1969 Jan 01; 264(3):221-2. PubMed ID: 4390696
    [No Abstract] [Full Text] [Related]

  • 15. [The inherent contractility-reducing effect of various beta-adrenolytic agents on a heart-lung preparation in the dog].
    Schmidt HD, Schmier J.
    Z Kreislaufforsch; 1967 Nov 01; 56(11):1137-50. PubMed ID: 5595876
    [No Abstract] [Full Text] [Related]

  • 16. [On the influence of beta-receptor blocking agents, iproveratril, quinidine and reserpine on the effect of k-strophanthin in the guinea pig heart].
    Fratz R, Greeff K, Wagner J.
    Naunyn Schmiedebergs Arch Exp Pathol Pharmakol; 1967 Nov 01; 256(2):196-206. PubMed ID: 4233000
    [No Abstract] [Full Text] [Related]

  • 17. [Differentiation between beta adrenergic and Ca 2+ antagonistic influencing components of beta receptor blockaders in the myocardium and in smooth muscles with special reference to Trasicor].
    Grün G, Byon KY, Kaufmann R, Fleckenstein A.
    Arztl Forsch; 1972 Nov 10; 26(11):369-78. PubMed ID: 4404592
    [No Abstract] [Full Text] [Related]

  • 18. [Oxygen uptake and carbon dioxide release by the human heart under the influence of iproveratril (Verapamil)].
    Rudolph W, Meister W, Kriener J.
    Arzneimittelforschung; 1971 Apr 10; 21(4):458-62. PubMed ID: 5108140
    [No Abstract] [Full Text] [Related]

  • 19. [The calcium-antagonistic fundamental effects of Verapamil on myocardial fibers and smooth muscle cells of the blood vessels].
    Fleckenstein A, Grün G, Byon KY.
    Minerva Med; 1975 May 23; 66(38):1827-37. PubMed ID: 1128823
    [Abstract] [Full Text] [Related]

  • 20. [Control of myocardial metabolism by verapamil. Sites of action and therapeutic effects].
    Fleckenstein A.
    Arzneimittelforschung; 1970 Sep 23; 20():Suppl 9a:1317+. PubMed ID: 5536556
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.